1. Academic Validation
  2. Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic

Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic

  • Antimicrob Agents Chemother. 2012 Mar;56(3):1584-7. doi: 10.1128/AAC.05532-11.
Johanne Blais 1 Stacey R Lewis Kevin M Krause Bret M Benton
Affiliations

Affiliation

  • 1 Theravance, Inc, South San Francisco, California, USA.
Abstract

TD-1792 is a new multivalent glycopeptide-cephalosporin Antibiotic with potent activity against Gram-positive bacteria. The in vitro activity of TD-1792 was tested against 527 Staphylococcus aureus isolates, including multidrug-resistant isolates. TD-1792 was highly active against methicillin-susceptible S. aureus (MIC(90), 0.015 μg/ml), methicillin-resistant S. aureus, and heterogeneous vancomycin-intermediate S. aureus (MIC(90), 0.03 μg/ml). Time-kill studies demonstrated the potent bactericidal activity of TD-1792 at concentrations of ≤ 0.12 μg/ml. A postantibiotic effect of >2 h was observed after exposure to TD-1792.

Figures
Products